Neuronetics, Inc. Q4 2025 Earnings Call Summary

6 days ago 5

Moby Intelligence

Tue, March 17, 2026 astatine 11:46 AM CDT 3 min read

Achieved the captious milestone of affirmative operating currency travel successful Q4 2025, validating the strategical thesis of the Greenbrook acquisition done gross maturation and disbursal discipline.
Delivered 23% adjusted pro forma gross maturation driven by grounds superior shipments and a 28% summation successful session revenue, reflecting palmy integration of the nationalist attraction transportation network.
Realigned the NeuroStar superior income squad to absorption connected 'TMS-ready' accounts—practices with existing unit and security credentialing—to accelerate the timeline from strategy acquisition to archetypal diligent treatment.
Expanded the referring supplier web by 25% year-over-year done a Regional Account Manager programme that completed implicit 47,000 doc outreach activities successful 2025.
Optimized session economics by implementing a disciplined, state-by-state attack to SPRAVATO billing, balancing 'buy-and-bill' versus 'administer-and-observe' models based connected payer dynamics.
Leveraged interior infrastructure to motorboat a B2B work model, providing benefits probe and diligent absorption enactment to outer nationalist endeavor accounts similar Transformations Care Network.

Projecting 2026 full gross betwixt $160 cardinal and $166 million, with session concern maturation expected successful the treble digits to mid-teens.
Implementing ratio initiatives to scope an annualized operating disbursal tally complaint of little than $100 cardinal by the 4th fourth of 2026.
Anticipating affirmative operating currency travel for the afloat 2nd fractional of 2026, pursuing emblematic first-quarter seasonality and yearly inducement outlays.
Piloting caller superior acquisition models successful Q1 2026 to supply flexible exertion entree for divers lawsuit segments beyond accepted acquisition structures.
Preparing for a imaginable 2027 commercialized motorboat of COMP360 psilocybin therapy, utilizing existing REMS-compliant infrastructure and objective unit astatine Greenbrook locations.

Announced a enactment modulation with Dan Reavers appointed arsenic President and CEO, effectual March 23, 2026, to pb the company's adjacent scaling phase.
Amended the indebtedness statement with Perceptive successful March 2026, including a $5.0 cardinal main paydown to trim involvement disbursal and optimize the equilibrium sheet.
Disclosed an ongoing probe by the U.S. Attorney's Office successful Florida regarding Greenbrook's billing practices anterior to its acquisition by Neuronetics.
Noted that Q1 2026 guidance reflects emblematic seasonality wherever diligent volumes and superior budgets are historically astatine their lowest yearly levels.